Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Nanosci Nanotechnol ; 11(3): 1880-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21449324

ABSTRACT

The interest in developing new sunscreens is increasing due to the harmful effects of UV radiation on the skin, such as erythema, accelerated skin ageing (photoageing) and the induction of skin cancer. However, many molecular sunscreens penetrate into the skin causing photoallergies, phototoxic reactions and skin irritation. Thus, the aim of this work was the preparation and characterization of polymeric and solid lipid nanoparticles to act carriers of benzophenone-3 (BZ3), aiming to improve the safety of sunscreen products by increasing the sun protection factor (SPF), decreasing BZ3 skin penetration and decreasing BZ3 concentration in sunscreen formulation. BZ3 was encapsulated in poly(epsilon-caprolactone) (PCL) nanoparticles by the nanoprecipitation method and in solid lipid nanoparticles (SLN) by the hot high pressure homogenization method. The particles were stable for 40 days. The BZ3 encapsulated in PCL nanoparticles was released faster than BZ3 encapsulated in SLN. The sun protection factor increased when BZ3 was encapsulated in both nanostructures. However, BZ3 encapsulated in PCL nanoparticles decreased its skin permeation more than SLN-BZ3. Furthermore, BZ3 encapsulated in SLN did not exhibit cytotoxic or phototoxic effects in human keratinocytes (HaCaT cells) and BABL/c 3T3 fibroblasts, whereas PCL nanoparticles with BZ3 showed phototoxic potential in HaCaT cells. Nevertheless, BZ3 free and encapsulated in PCL nanoparticles or in SLN did not show allergic reactions in mice. Our results suggest that these nanostructures are interesting carriers for sunscreen.


Subject(s)
Lipids/chemistry , Nanocapsules/chemistry , Polymers/chemistry , Skin Absorption/physiology , Skin/drug effects , Sunscreening Agents/chemistry , Sunscreening Agents/pharmacokinetics , Administration, Topical , Animals , Humans , Mice , Nanocapsules/administration & dosage , Sunscreening Agents/administration & dosage
2.
Int Endod J ; 39(1): 40-7, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16409327

ABSTRACT

AIM: To compare the cytotoxicity of materials used to repair perforations using permanent V79 fibroblasts and murine granulocyte-macrophage progenitor cells (CFU-GM). METHODOLOGY: Set specimens from amalgam, glass-ionomer, SuperEBA, N-Rickert, MTA and gutta-percha were eluted with culture medium for 72 h and their cytotoxicities were assessed by incubating the extracts with V79 and bone marrow-derived progenitors for 24 h and 7 days, respectively. Cytotoxicity on V79 cells was judged using the total nucleic acid content (NAC), neutral red uptake (NRU) and reduction of the tetrazolium salt (MTT). The number of bone marrow CFU-GM colonies determined in clonal cultures stimulated with recombinant murine granulocyte-macrophage colony-stimulating factor was used to assess cytotoxicity to progenitor cells. Statistical analyses were conducted using the one-way analysis of variance and Tukey's test where appropriate. RESULTS: All materials were cytotoxic in both cell systems; however, CFU-GM was more sensitive to the extracts than V79 cells. A similar rank order of toxicity was observed in V79 cells using the NAC and the MTT assays: glass-ionomer > N-Rickert congruent with SuperEBA > gutta-percha > amalgam congruent with MTA (P < 0.05). In contrast, the NRU test exhibited a lower sensitivity to MTA, gutta-percha and amalgam extracts. In the clonal culture assay, the toxicity was less pronounced in the presence of gutta-percha, SuperEBA and MTA. Similar cellular responses were found by placing the set specimens directly in the clonal culture dishes. CONCLUSIONS: The sensitivity of toxicity depended on the choice of the endpoint and the cell-culture system. Nevertheless, MTA was ranked as the least cytotoxic cement in both cell systems.


Subject(s)
Aluminum Compounds/toxicity , Calcium Compounds/toxicity , Fibroblasts/drug effects , Hematopoietic Stem Cells/drug effects , Oxides/toxicity , Root Canal Filling Materials/toxicity , Silicates/toxicity , Acrylic Resins/toxicity , Animals , Cell Line , Cricetinae , Dental Amalgam/toxicity , Dentin-Bonding Agents/toxicity , Drug Combinations , Granulocyte Precursor Cells/drug effects , Gutta-Percha/toxicity , Macrophages/drug effects , Mice , Silicon Dioxide/toxicity
3.
J Enzyme Inhib Med Chem ; 20(5): 449-54, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16335052

ABSTRACT

Given the importance of protein phosphorylation in the context of cellular functions, abnormal protein phosphatase activity has been implicated in several diseases, including cancer. These critical roles of protein phosphatases qualify them as potential targets for the development of medicinal compounds that possess distinct modes of action such as violacein. In this work, studies with this natural indolic pigment at a concentration of 10.0 micromol L(-1) demonstrated a 20% activation of total protein phosphatase extracted from human lymphocytes. Although no alteration was observed on protein tyrosine phosphatase (CD45), 30% of inhibition was achieved in cytoplasmatic protein phosphatase activity after incubation with 10.0 micromol L(-1) violacein. Additionally, 5.0 micromol L(-1) of violacein inhibited by 50% the serum tartrate-resistant acid phosphatase activity. Violacein presented toxic effect on lymphocytes with IC50 values of 3 and 10 micromol L(-1) for protein content and protein phosphatase activity, respectively. These findings suggest an important role for protein phosphatases in the mechanisms controlling proliferation and cell death.


Subject(s)
Indoles/toxicity , Lymphocytes/drug effects , Lymphocytes/enzymology , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Phosphoric Monoester Hydrolases/metabolism , Cells, Cultured , Humans , Indoles/chemistry , Lymphocytes/cytology , Molecular Structure , Phosphoric Monoester Hydrolases/blood
4.
Immunopharmacol Immunotoxicol ; 25(3): 305-19, 2003 Aug.
Article in English | MEDLINE | ID: mdl-19180795

ABSTRACT

The present study examined the effects of MAPA, an antitumor aggregated polymer of protein magnesium ammonium phospholinoleate-palmitoleate anhydride, isolated from Aspergillus oryzae, on concanavalin A (Con A)-induced spleen cell proliferation, cytokine production and on natural killer (NK) cell activity in Ehrlich ascites tumor-bearing mice. The Ehrlich ascites tumor (EAT) growth led to diminished mitogen-induced expansion of spleen cell populations and total NK activity. This was accompanied by striking spleen enlargement, with a marked increase in total cell counts. Moreover, a substantial enhancement in IL-10 levels, paralleled by a significant decrease in IL-2 was observed, while production of IL-4 and interferon-gamma (IFN-gamma) was not altered. Treatment of mice with 5 mg/kg MAPA for 7 days promoted spleen cell proliferation, IL-2 production and NK cell activity regardless of tumor outgrowth. In addition, MAPA treatment markedly enhanced IFN-gamma levels and reduced IL-10 production relative to EAT mice. A 35% reduction in splenomegaly with normal number of nucleated cells was also found. Altogether, our results suggest that MAPA directly and/or indirectly modulates immune cell activity, and probably disengages tumor-induced suppression of these responses. Clearly, MAPA has an impact and may delay tumor outgrowth through immunotherapeutic mechanisms.


Subject(s)
Antineoplastic Agents/pharmacology , Aspergillus oryzae , Carcinoma, Ehrlich Tumor/drug therapy , Cell Proliferation/drug effects , Cytokines/metabolism , Killer Cells, Natural/drug effects , Linoleic Acids/pharmacology , Lymphocytes/drug effects , Organophosphorus Compounds/pharmacology , Spleen/drug effects , Animals , Antineoplastic Agents/isolation & purification , Aspergillus oryzae/chemistry , Carcinoma, Ehrlich Tumor/immunology , Carcinoma, Ehrlich Tumor/pathology , Cells, Cultured , Concanavalin A/pharmacology , Killer Cells, Natural/immunology , Linoleic Acids/isolation & purification , Lymphocytes/immunology , Male , Mice , Mice, Inbred BALB C , Mitogens/pharmacology , Organophosphorus Compounds/isolation & purification , Spleen/immunology , Spleen/pathology , Splenomegaly/immunology , Splenomegaly/prevention & control , Time Factors , Tumor Escape/drug effects
5.
Immunopharmacol Immunotoxicol ; 23(3): 367-82, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11694028

ABSTRACT

The capacity of hematopoietic tissues to produce and mobilize phagocytes to the site of infection and tumor growth is of central importance to mediate the early immunological response. In this perspective, studies from our laboratory have defined Listeria monocytogenes infection and the Ehrlich ascites tumor (EAT) as useful models to investigate the effects of natural compounds on the growth and differentiation of granulocyte-macrophage progenitor cells (CFU-GM). As expected, a significant reduction in the number of bone marrow CFU-GM was observed in the initial stages of infection with a sublethal dose of Listeria. Similarly, the bone marrow CFU-GM decreased sharply 4 days after the EAT transplantation. Treatment of infected and tumor-bearing mice with 500 and 1,000 mg/kg of Caesalpinia ferrea aqueous extract, given 3 times orally, significantly stimulated myelopoiesis, whereas no effects were observed with the 250 mg/kg dose. Similar results were obtained in normal mice. The administration of the two higher doses of the extract also protected 15-20% of mice from a lethal dose of Listeria and significantly prolonged survival of EAT-bearing mice. In summary, these results demonstrate that C. ferrea extract acts as a positive regulator of myelopoiesis, and suggest that the therapeutic effect of C. ferrea may be partially mediated by this action.


Subject(s)
Caesalpinia , Carcinoma, Ehrlich Tumor/drug therapy , Carcinoma, Ehrlich Tumor/pathology , Hematopoiesis/drug effects , Listeriosis/drug therapy , Listeriosis/pathology , Phytotherapy , Plant Extracts/pharmacology , Administration, Oral , Animals , Carcinoma, Ehrlich Tumor/immunology , Colony-Forming Units Assay , Dose-Response Relationship, Drug , Granulocytes/drug effects , Granulocytes/pathology , Listeriosis/immunology , Macrophages/drug effects , Macrophages/pathology , Mice , Mice, Inbred BALB C , Plant Extracts/administration & dosage
6.
Immunopharmacol Immunotoxicol ; 23(2): 215-28, 2001 May.
Article in English | MEDLINE | ID: mdl-11417849

ABSTRACT

Progressive tumor growth is regularly accompanied by changes in the cellular constituents of the immune system. Evidence suggests that soluble factors generated during tumor growth can affect the amount of granulocyte-macrophage progenitors. In vitro colony growth of progenitor cells may be an early indicator of the cellular changes associated with tumor growth. Pluchea quitoc has been previously found to modulate the hematopoietic response during bacterial infection. This study was designed to investigate the effects of P. quitoc on the growth and differentiation of bone marrow granulocyte-macrophage progenitor cells (CFU-GM) in Ehrlich ascites tumor-bearing mice. In contrast to the myelosuppression developed in the tumor-bearing animals, treatment with P. quitoc ethanolic extract (250, 500 or 1000 mg/kg) for 3 consecutive days after tumor challenge reversibly stimulated myelopoiesis, restoring the number of CFU-GM to normal. This same dose-schedule also increased colony formation in normal mice as compared to controls. In addi tion, P. quitoc significantly enhanced survival of tumor-bearing mice. These results suggest an immunoregulatory role for P. quitoc in counteracting the tumor-induced myelopoietic suppression as well as usefulness as adjuvant treatment of cancer.


Subject(s)
Asteraceae , Carcinoma, Ehrlich Tumor/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/therapeutic use , Animals , Carcinoma, Ehrlich Tumor/immunology , Carcinoma, Ehrlich Tumor/pathology , Colony-Forming Units Assay , Hematopoiesis/drug effects , Male , Mice , Mice, Inbred BALB C , Plant Extracts/administration & dosage
7.
Hum Exp Toxicol ; 20(1): 38-45, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11339624

ABSTRACT

In this work, we investigated the effects of the proteic aggregated polymer of magnesium ammonium phospholinoleate-palmitoleate anhydride (MAPA) isolated from Aspergillus oryzae on the growth and differentiation of bone marrow granulocyte-macrophage progenitor cells (CFU-GM) in Listeriamonocytogenes-infected mice. A significant reduction in the CFU-GM number was observed in the initial phase of infection with a sublethal dose of Listeria. Treatment of mice with 0.5, 2.0 and 5.0 mg/kg MAPA for 7 days prior to infection significantly stimulated myelopoiesis in a dose-dependent manner. Moreover, treatment with 0.5 and 5.0 mg/kg MAPA resulted in 30% and 40% cures of mice lethally infected with Listeria, respectively. MAPA added directly to the culture dishes hardly affected colony formation by bone marrow cells, suggesting an indirect effect ofthis compound on myelopoiesis in vivo. In summary, the data show that MAPA can modulate the CFU-GM generation and antibacterial resistance in listeriosis. As the ability of hematopoietic tissues to produce phagocytes is of particular significance to mediate resistance to Listeria, the promotion of bone marrow CFU-GM by MAPA may contribute to a rapid restoration of phagocyte numbers in infected sites, thus mitigating the course of infection.


Subject(s)
Aspergillus oryzae/chemistry , Leukopoiesis/drug effects , Listeriosis/pathology , Polymers/therapeutic use , Animals , Bone Marrow Cells/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Injections, Subcutaneous , Male , Mice , Mice, Inbred BALB C , Recombinant Proteins , Stem Cells/drug effects , Survival Analysis
8.
Immunopharmacol Immunotoxicol ; 23(1): 119-32, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11322644

ABSTRACT

Chlorella vulgaris extract (CVE) was examined for its effects on the Ehrlich ascites tumor-induced suppression in the numbers of bone marrow and spleen granulocyte-macrophage progenitor cells (CFU-GM) in mice. No effects on bone marrow and spleen CFU-GM, as compared to controls, were observed in normal mice given 50, 100 and 200 mg/kg CVE orally for 5 days. In tumor-bearing mice, myelosuppression concomitant with increased number of spleen CFU-GM were observed. The number of CFU-GM in the bone marrow was restored to control levels after the administration of CVE (50, 100 and 200 mg/kg) to tumor-bearing mice, and a slight reduction in spleen colony formation was observed in these animals. In addition, CVE significantly prolonged the survival of mice inoculated with the Ehrlich ascites tumor. These results suggest a protective antitumor effect of CVE which might be attributable, at least in part, to the stimulation of the production and, possibly, maturation of granulocytes and macrophages.


Subject(s)
Bone Marrow Cells/drug effects , Carcinoma, Ehrlich Tumor/immunology , Chlorella , Granulocyte-Macrophage Colony-Stimulating Factor/drug effects , Hematopoietic Stem Cells/drug effects , Leukopoiesis/drug effects , Plant Extracts/pharmacology , Administration, Oral , Animals , Cells, Cultured , Colony-Forming Units Assay , Germ-Free Life , Hematopoiesis, Extramedullary/drug effects , Injections, Intraperitoneal , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Plant Extracts/analysis , Recombinant Proteins , Spleen/cytology , Survival Rate
9.
Immunopharmacol Immunotoxicol ; 22(4): 721-40, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11105784

ABSTRACT

The importance of both granulocytes and macrophages in the response to Listeria monocytogenes infection make this infection a suitable choice to investigate the effects of Pluchea quitoc on hematopoiesis. A significant depletion of bone marrow granulocyte-macrophage progenitor cells (CFU-GM) was observed at 48 and 72 h after intraperitoneal infection of mice with 1 x 10(4) L. monocytogenes. However, the treatment of infected animals with P. quitoc ethanolic extract (250, 500 or 1000 mg/kg) given orally for 3 consecutive days prior to infection produced a stimulatory effect on myelopoiesis, restoring the number of CFU-GM to normal. This same dose-schedule also increased colony formation in normal mice as compared to controls. In addition, P. quitoc significantly enhanced survival of infected mice. Thus, it is probable that the ability of P. quitoc to induce a higher reserve of granulocyte-macrophage precursors in the bone marrow is of major significance in determining early resistance to infection.


Subject(s)
Hematopoiesis/drug effects , Listeriosis/drug therapy , Listeriosis/immunology , Plant Extracts/pharmacology , Animals , Colony-Forming Units Assay , Granulocytes/drug effects , Granulocytes/immunology , Granulocytes/pathology , Listeriosis/pathology , Macrophages/drug effects , Macrophages/immunology , Macrophages/pathology , Male , Mice , Mice, Inbred BALB C , Plants, Medicinal
10.
Eur J Pharmacol ; 388(3): 219-26, 2000 Feb 04.
Article in English | MEDLINE | ID: mdl-10675729

ABSTRACT

The effects of magnesium ammonium phospholinoleate-palmitoleate anhydride (MAPA), a proteic aggregated polymer isolated from Aspergillus oryzae, on the growth and differentiation of granulocyte-macrophage progenitor cells (colony-forming unit-granulocyte-macrophage [CFU-GM]) in normal and Ehrlich ascites tumour-bearing mice were studied. Myelosuppression concomitant with increased numbers of spleen CFU-GM was observed in tumour-bearing mice. Treatment of these animals with MAPA (0.5-10 mg/kg) stimulated marrow myelopoiesis in a dose-dependent manner and reduced spleen colony formation. No changes were observed in total and differential marrow cell counts. The dose of 5.0 mg/kg MAPA, given prior or after tumour inoculation, was the optimal biologically active dose in tumour-bearing mice and this dose schedule also stimulated myelopoiesis in normal mice. MAPA significantly enhanced survival and concurrently reduced tumour growth in the peritoneal cavity. We propose that the modulatory effect of MAPA on the myelopoietic response may be related to its antitumour activity as a possible mechanism for regulation of granulocyte-macrophage production and expression of functional activities.


Subject(s)
Antineoplastic Agents/pharmacology , Aspergillus oryzae/chemistry , Carcinoma, Ehrlich Tumor/pathology , Linoleic Acids/pharmacology , Organophosphorus Compounds/pharmacology , Animals , Antineoplastic Agents/chemistry , Bone Marrow Cells/drug effects , Bone Marrow Cells/pathology , Granulocytes/drug effects , Granulocytes/pathology , Linoleic Acids/chemistry , Macrophages/drug effects , Macrophages/pathology , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Organophosphorus Compounds/chemistry , Spleen/drug effects , Spleen/pathology , Stem Cells/drug effects , Stem Cells/pathology
11.
Physiol Chem Phys Med NMR ; 32(2): 145-54, 2000.
Article in English | MEDLINE | ID: mdl-11383136

ABSTRACT

Xanthine oxidase (XO) has been investigated for its decreased activity in several cancerous tissues and constitutive generation of reactive oxygen species (ROS) in vivo seems to contribute significantly to its inactivation. Singlet oxygen (1O2) production has been suggested to be relevant when considering folic acid metabolism by cancer cells. Thus, the susceptibility of XO to inactivation by 1O2 generated either by the bioenergized systems folic acid/peroxidase/GSH/Mn2+/O2 and malonaldehyde/peroxidase/Mn2+/O2 or by methylene blue (MB) or eosin-sensitized photooxygenation was studied. Our results showed that other ROS were also responsible for XO inactivation when MB was used. In contrast, eosin produced almost exclusively 1O2. Kinetic studies of XO oxidation in the malonaldehyde/peroxidase system showed that histidine (His) is a competitive inhibitor with respect to XO. A similar result was observed in the eosin-photosensitized process, suggesting the involvement of 1O2 in both processes. In addition, an efficient quenching of XO oxidation by guanosine in the folic acid/peroxidase system was observed. Amino acid analysis revealed that cysteine (Cys) is more affected than other XO amino acids also prone to oxidation such as tyrosine (Tyr), methionine (Met) and His. These results indicate that 1O2 may cause oxidative damage to the Cys residues of XO, with loss of enzyme activity. Alteration of the flavin prosthetic site is hypothesized.


Subject(s)
Cysteine/chemistry , Peroxidase/chemistry , Reactive Oxygen Species , Xanthine Oxidase/chemistry , Amino Acids/chemistry , Catalysis , Folic Acid/chemistry , Glutathione/chemistry , Horseradish Peroxidase/chemistry , Indicators and Reagents , Malondialdehyde/chemistry , Oxidation-Reduction , Photochemistry , Spectrometry, Fluorescence
12.
Free Radic Biol Med ; 19(4): 431-40, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7590392

ABSTRACT

The possible action of carbon-centered radicals in promoting damage to DNA is explored by generation of the 2-phenylethyl radical. The radical is generated during oxidation of phenelzine (2-phenylethyl hydrazine) by ferricyanide, as well as optically from phenylpropionic acid. Covalent binding of the 2-phenylethyl radical to DNA is suggested by studies with the plasmid pBR 322 DNA. Other sensitive techniques used to study DNA damage were the interaction with formaldehyde at 60 degrees C and the fluorescence of DNA-Tb(III) and DNA-DAPI complexes. Theoretical MNDO calculations indicated a preferential attack at position 8 of the guanine residues. This study shows that the 2-phenylethyl radical is able to induce primary effects on nucleic acid structure, leading to alkylated products, especially at purine rings.


Subject(s)
DNA Damage , DNA/chemistry , Phenelzine/chemistry , Alkylation , DNA/metabolism , Electron Spin Resonance Spectroscopy , Ferricyanides/chemistry , Fluorescent Dyes , Free Radicals , Indoles , Intercalating Agents , Oxidation-Reduction , Phenylpropionates/chemistry , Phenylpropionates/radiation effects , Photolysis , Spectrometry, Fluorescence , Terbium
SELECTION OF CITATIONS
SEARCH DETAIL
...